ClinicalTrials.gov
skipnavHome|Search|Browse|Resources|Help|What's New|About

Browse : By Sponsor : Industry : Glaxo Wellcome


Include trials that are no longer recruiting patients.

120 studies were found. Here are studies 1 to 50.
1.Completed3TC (Lamivudine; GR109714X) Open-Label Program
Condition: HIV Infections
2.CompletedThe Antiviral Efficacy of Concurrent Zidovudine and 2',3'-dideoxyinosine or 2',3'-dideoxycytidine in Patients with Human Immunodeficiency Virus Disease
Condition: HIV Infections
3.CompletedA Comparative Study of a Combination of Zidovudine, Didanosine, and Double-Blinded Nevirapine Versus a Combination of Zidovudine and Didanosine
Condition: HIV Infections
4.CompletedA Comparative Trial of Valacyclovir Hydrochloride ( 256U87 ) and Acyclovir for the Suppression of Anogenital Herpes Infections in HIV-Infected Patients
Conditions: Herpes Simplex; HIV Infections
5.CompletedA Comparison of 141W94 and Indinavir in HIV-Infected Patients
Condition: HIV Infections
6.CompletedComparison of 2',3'-Dideoxyinosine (Didanosine, ddI) and Zidovudine in Therapy of Patients With the AIDS Dementia Complex
Conditions: AIDS Dementia Complex; HIV Infections
7.CompletedA Comparison of 882C87 Versus Acyclovir in the Treatment of Herpes Zoster in Patients with Weakened Immune Systems
Conditions: HIV Infections; Chickenpox
8.CompletedA Comparison of Atovaquone and Pentamidine in the Prevention of Pneumocystis Carinii Pneumonia in HIV-Infected Patients Who Cannot Take TMP/SMX
Conditions: Pneumonia, Pneumocystis carinii; HIV Infections
9.CompletedComparison of Brovavir Versus Acyclovir in the Treatment of Herpes in HIV-Infected Patients
Conditions: HIV Infections; Chickenpox
10.No longer recruitingComparison of GW433908 and Nelfinavir in HIV Patients Who Have Not Had Antiretroviral Therapy
Condition: HIV Infections
11.No longer recruitingComparison of GW433908/Ritonavir to Nelfinavir When Used with Abacavir and Lamivudine in Patients That Have Not Taken Antiretroviral Drugs
Condition: HIV Infections
12.CompletedA Comparison of Lamivudine and Zidovudine, Used Alone and Together, in HIV-Infected Patients Who Have Not Used Zidovudine in the Past
Condition: HIV Infections
13.CompletedComparison of Three Anti-HIV Drug Combinations in HIV-Infected Patients with No Symptoms of the Disease
Condition: HIV Infections
14.CompletedA Comparison of Three Anti-HIV Drug Combinations in HIV-Infected Patients
Condition: HIV Infections
15.CompletedA Comparison of Three Treatments for Advanced HIV Disease in Patients Who Have Received Nucleoside Therapy in the Past
Condition: HIV Infections
16.CompletedA Comparison of Two Multi-Drug Therapies in HIV-Infected Patients Who Have Never Received Anti-HIV Treatment
Condition: HIV Infections
17.CompletedA Comparison of Zidovudine Plus Lamivudine Versus ddI Used Alone or in Combination with Zidovudine in HIV-1 Infected Children
Condition: HIV Infections
18.CompletedCSP #428 - Treatment of Seizures in the Elderly Population
Condition: seizures in the elderly
19.CompletedA Dose-Frequency Trial of Oral Retrovir in Patients With AIDS or Severe ARC
Condition: HIV Infections
20.CompletedThe Effect of Teaching HIV-Infected Patients about HIV and Treatment
Condition: HIV Infections
21.CompletedThe Effect of Valacyclovir on the Detection of HIV from Genital Herpes Lesions in HIV-Infected Patients
Conditions: Herpes Simplex; HIV Infections
22.No longer recruitingEffectiveness and Safety of Epivir/Ziagen/Zerit (3TC/ABC/d4T) Versus Epivir/Ziagen/Sustiva (3TC/ABC/EFV) Versus Epivir/Ziagen/Agenerase/Norvir (3TC/ABC/APV/RTV) in HIV Patients Who Have Never Received Treatment
Condition: HIV Infections
23.RecruitingEffectiveness of Adding Interleukin-2 to Anti-HIV Drugs in Patients Recently Infected with HIV
Condition: HIV Infections
24.CompletedThe Effects of Anti-HIV Drugs in HIV-Infected Patients Who Do Not Have AIDS
Condition: HIV Infections
25.CompletedThe Effects of Zidovudine on the Blood of HIV-Infected Patients
Condition: HIV Infections
26.CompletedThe Efficacy and Safety of Retrovir in Patients Infected With HIV Who Are Asymptomatic (CDC Group II) or Have Persistent Generalized Lymphadenopathy (CDC Group III)
Conditions: Lymphatic Disease; HIV Infections
27.CompletedEvaluation of Patients Who Have Not Had Success with Zidovudine
Condition: HIV Infections
28.No longer recruitingFour-Drug Combination Therapy with Zidovudine, Lamivudine, 1592U89 (Abacavir), and 141W94 (Amprenavir) in HIV-Infected Patients
Condition: HIV Infections
29.CompletedGradual Initiation of Sulfamethoxazole/Trimethoprim as Primary Pneumocystis carinii Pneumonia Prophylaxis
Conditions: Pneumonia, Pneumocystis carinii; HIV Infections
30.CompletedMethadone Effects on Zidovudine (ZDV, AZT) Disposition
Condition: HIV Infections
31.CompletedA Multicenter Phase II Double-Blind Exploratory Study to Evaluate Differences Among Various Zidovudine/Didanosine Regimens on Quantitative Measures of Viral Burden in Relatively Early HIV-1 Infection
Condition: HIV Infections
32.CompletedAn Open-Label Study to Evaluate the Efficacy and Safety of Amprenavir (141W94) and Abacavir Combination Therapy in Protease Inhibitor Experienced Subjects with HIV-1 Infection Who Are Failing Their Current Antiretroviral Treatment Regimen
Condition: HIV Infections
33.CompletedAn Open-Label, Uncontrolled Clinical Trial of Oral 566C80 for the Treatment of Patients with Severe PCP Who Are Intolerant and/or Unresponsive to Therapy with Trimethoprim/Sulfamethoxazole and Parenteral Pentamidine
Conditions: Pneumonia, Pneumocystis carinii; HIV Infections
34.CompletedAn Oral Dose-Ranging Finding Study in Patients With HIV Disease, CDC Classification Groups IIB, III, and IV-C2
Condition: HIV Infections
35.CompletedA Phase I Concentration-Controlled Trial to Assess the Safety, Tolerance, Pharmacokinetics and Development of Decreased HIV-1 Susceptibility to the Combination of Atevirdine Mesylate (U-87201E), Zidovudine (AZT), and Didanosine (ddI)
Condition: HIV Infections
36.CompletedA Phase I Concentration-Targeted Multidose Study of Atevirdine Mesylate ( U-87201E ), AZT, and ddI or ddC
Condition: HIV Infections
37.CompletedA Phase I Study to Evaluate the Pharmacokinetics, Safety and Antiviral Effects of Concurrent Administration of Zidovudine (AZT) and 2'3'-Dideoxyinosine (ddI) in Patients With Human Immunodeficiency Virus (HIV)
Condition: HIV Infections
38.CompletedA Phase I Trial to Evaluate the Safety, Pharmacokinetics and Antiviral Activity of 141W94 After Multiple Dosing in Patients with HIV Infection
Condition: HIV Infections
39.CompletedA Phase I, Dose-Escalating Safety and Tolerance Study of sCD4-PE40 in HIV-Infected Persons
Condition: HIV Infections
40.CompletedA Phase I/II Trial of Vaccine Therapy of HIV-1 Infected Individuals With 50-500 CD4 Cells/mm3
Condition: HIV Infections
41.CompletedA Phase I/II, Open Label Study to Evaluate the Antiviral Potential of Combination Zidovudine and 2' 3'-Dideoxyinosine (Didanosine) in Patients With Asymptomatic HIV Disease
Condition: HIV Infections
42.CompletedA Phase II Double-Blind Study of Two Doses of SC-49483 in Combination With Zidovudine (ZDV) Versus ZDV
Condition: HIV Infections
43.CompletedA Phase II Open Randomized Comparison of 566C80 and Pentamidine Isethionate for the Treatment of Pneumocystis carinii Pneumonia in AIDS Patients Who are Intolerant of Trimethoprim / Sulfamethoxazole
Conditions: Pneumonia, Pneumocystis carinii; HIV Infections
44.CompletedA Phase III Comparative Study of Dapsone / Trimethoprim and Clindamycin / Primaquine Versus Sulfamethoxazole / Trimethoprim in the Treatment of Mild-to-Moderate PCP in Patients With AIDS
Conditions: Pneumonia, Pneumocystis carinii; HIV Infections
45.CompletedA Phase III Randomized Double-Blind, Multicenter Study to Evaluate the Safety and Efficacy of 3TC/ZDV/1592U89 and 3TC/ZDV/IDV in HIV-1 Infected Antiretroviral Therapy-Naive Subjects.
Condition: HIV Infections
46.CompletedA Phase III Study to Evaluate the Safety, Tolerance, and Efficacy of Early Treatment With Zidovudine (AZT) in Asymptomatic Infants With HIV Infection
Condition: HIV Infections
47.CompletedA Phase III, Randomized, Double-Blind, Multicentre Study to Evaluate the Safety and Efficacy of 1592U89 in Patients With AIDS Dementia Complex
Conditions: AIDS Dementia Complex; HIV Infections
48.CompletedA Pilot Randomized, Double-Blind, Placebo-Controlled, Parallel Design, Multicenter Trial to Evaluate the Effect of Ranitidine on Immunologic Indicators in Asymptomatic HIV-1 Infected Subjects With a CD4 Cell Count Between 400-700 Cells/mm3
Condition: HIV Infections
49.CompletedA Pilot Study of 566C80 for the Salvage Treatment of Toxoplasmic Encephalitis in Patients Infected With the Human Immunodeficiency Virus (HIV) Who Have Failed or are Intolerant of Pyrimethamine-Sulfadiazine
Conditions: Toxoplasmosis, Cerebral; HIV Infections
50.CompletedA Pilot Study of Oral Clindamycin and Pyrimethamine for the Treatment of Toxoplasmic Encephalitis in Patients With AIDS
Conditions: Toxoplasmosis, Cerebral; HIV Infections

line
U.S. National Library of Medicine, Contact NLM Customer Service
National Institutes of Health, Department of Health & Human Services
Copyright, Privacy, Accessibility, Freedom of Information Act